SCHEMBL30987741

SCHEMBL30987741

Cc1ncc(-c2ccc(F)c(C(=O)O)c2)s1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ASPH Q12797 1/20 0.41
▸ KDM8 Q8N371 1/20 0.41
▸ PDE5A O76074 1/20 0.40
▸ PDE1A P54750 1/20 0.40
▸ PDE1B Q01064 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ PDE7A Q13946 1/20 0.40
▸ PDE1C Q14123 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ WNT1 P04628 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ CSNK2A1 P68400 1/20 0.39
▸ P2RX7 Q99572 1/20 0.39
▸ AOC3 Q16853 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27272895 1.00 HCAR2 (0.42) HCAR2KDM4EASPHKDM8PDE5A
SCHEMBL27272881 0.89 RARB (0.45) HCAR2AOC3
SCHEMBL30987626 0.89 RARB (0.45) HCAR2AOC3
SCHEMBL30987637 0.85 GSK3B (0.40) KDM4EWNT1GSK3BDYRK1AP2RX7
SCHEMBL27272866 0.85 GSK3B (0.40) KDM4EWNT1GSK3BDYRK1AP2RX7
SCHEMBL2408026 0.80 AOC3 (0.45) KDM4EPDE3AWNT1GSK3BDYRK1A
SCHEMBL17336591 0.78 HDAC4 (0.48) —
SCHEMBL30987780 0.77 CTSK (0.43) KDM4EWNT1GSK3BDYRK1AAOC3
SCHEMBL27272844 0.77 CTSK (0.43) KDM4EWNT1GSK3BDYRK1AAOC3
SCHEMBL984312 0.76 AOC3 (0.39) PDE3AWNT1GSK3BDYRK1AAOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676929-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2026-01-14 — — EP disclosed
EP-4638447-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS Dark Blue Therapeutics Ltd (GB) 2025-10-29 — — EP disclosed
WO-2024188906-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2024-09-19 — — WO disclosed
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 — — WO disclosed
Send feedback